Financial News
All News about AbbVie
![](https://g.foolcdn.com/editorial/images/757472/group-of-investors-looking-at-charts.jpg)
![](https://investorplace.com/wp-content/uploads/2019/08/healthcare1600c.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/07/abbvie.jpg?width=1200&height=800&fit=crop)
AbbVie's New $9B Neuroscience Space Deal Might Attract FTC Scrutiny, Analyst Signals
December 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/07/cerevel_therapeutics_stock_cere_shares_abbv_abbvie_buyout_ai_generated.jpg?width=1200&height=800&fit=crop)
Why Cerevel Therapeutics Stock Is Higher
December 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/07/image17.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/756931/a-doctor-looking-at-a-tablet-with-another-person.jpg)
Is AbbVie Stock a Buy Now?
December 07, 2023
Via The Motley Fool
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Decoding AbbVie's Options Activity: What's the Big Picture?
December 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/07/methode_electronics_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/06/abbvie.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/07/image15.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Analyst Ratings for AbbVie
December 01, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/757225/man-with-arms-behind-head-looking-at-laptop.jpg)
![](https://g.foolcdn.com/editorial/images/757347/gettyimages-1178121483.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/12/06/medicine-257349_12802.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/01/dividend-stocks-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/small-cap-1600-1024x576.png)
![](https://investorplace.com/wp-content/uploads/2019/10/medicine.jpg)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/12/04/immunogen.jpg?width=1200&height=800&fit=crop)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
AbbVie's Big Buy Of ImmunoGen Opens Doors For Potential Investment Gains
December 04, 2023
Via Talk Markets
![](https://www.marketbeat.com/logos/articles/med_20231204070745_doing-your-holiday-shopping-these-stocks-might-mak.jpg)
![](https://g.foolcdn.com/editorial/images/756237/physician-giving-a-high-five-to-a-young-patient.jpg)
![](https://g.foolcdn.com/editorial/images/754631/getty-dividend-income.jpg)
5 S&P 500 Stocks That Pay a Generous Dividend
December 02, 2023
Via The Motley Fool
Topics
Stocks
Exposures
US Equities
![](https://www.investors.com/wp-content/uploads/2023/11/Stock-cybertruck-new-01-company.jpg)
![](https://www.marketbeat.com/logos/articles/med_20231201070958_these-biotechs-targeting-multiple-neurodegenerativ.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://g.foolcdn.com/editorial/images/756715/medical-professional-holding-dollar-sign-paperweight.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/30/imgn.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2020/06/abbvie.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.